Sepsis Detection Made Rapid and Accurate with Dr. Rolland Carlson CEO of Immunexpress

Join us with guest Dr. Rolland Carlson, CEO of Immunexpress to talk about the transformative work happening in sepsis diagnosis. Dr. Carlson discusses the importance of rapid sepsis diagnosis. The episode covers challenges faced during product development, regulatory achievements, and future plans for sepsis diagnostics. Dr. Carlson also shares advice on ensuring product quality and navigating FDA clearances. 00:00 Introduction to From Lab to Launch 00:25 Meet Dr. Rolland Carlson, CEO of Immunexpress 01:31 Challenges and Innovations in Sepsis Diagnosis 03:01 Impact of COVID-19 on Clinical Trials 04:17 The Vision Behind Septicite Rapid 05:17 Technical Insights into Sepsis Diagnosis 14:00 Regulatory Achievements and Quality Management 16:58 Integrating Septicite Rapid in Clinical Workflows 24:00 Future Innovations in Sepsis Diagnostics 25:34 A Personal Note from Dr. Carlson 26:29 Conclusion and Farewell https://immunexpress.com/  https://www.linkedin.com/in/rollie-carlson-ph-d-059074a/  Qualio website: https://www.qualio.com/ Previous episodes: https://www.qualio.com/from-lab-to-launch-podcast Apply to be on the show: https://forms.gle/uUH2YtCFxJHrVGeL8 Music by keldez